Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Interleukin 17 receptor B (IL17RB) ELISA Kit-Sandwich

Name: Canine Interleukin 17 receptor B (IL17RB) ELISA Kit-Sandwich
SKU: EK10F718
Rating: 5 (1 reviews)

Cat. No.EK10F718

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Canine IL17RB ELISA Kit-Sandwich is designed for the quantitative determination of Canine IL17RB in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine IL17RB.

Target Species Canine

Species Reactivity Canine

Detection Range 125-8000 pg/mL

Sensitivity 25 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Interleukin 17 receptor B is encoded by the IL17RB gene in dogs. Several reports have shown the association between the IL17B/IL17RB signaling pathway and tumor development in breast, gastric, lung, pancreas, prostate, brain and blood cancers.

Target/Biomarker Canine IL17RB

Target Synonym interleukin 17 receptor B

Gene ID 476587

UniProt ID A0A8C0PL28

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Sun, Y. et al. IL17RB and IL17REL expression are associated with improved prognosis in HPV-infected head and neck squamous cell carcinomas. Pathogens (Basel, Switzerland). 2023, 12: 572.